Von Willebrand factor-specific antibodies developing upon treatment of FVIII-deficient mice with different FVIII preparations.
Kallas
Ade
A
Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia. ade@ebc.ee
Kuuse
Sulev
S
Maimets
Toivo
T
Pooga
Margus
M
D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D019774:Blood Coagulation Factor Inhibitors / Q000276:immunology*; D004195:Disease Models, Animal; D005169:Factor VIII / Q000276:immunology* / Q000494:pharmacology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy / Q000276:immunology*; D051379:Mice; D008817:Mice, Mutant Strains; D014841:von Willebrand Factor / Q000276:immunology* / Q000494:pharmacology / Q000627:therapeutic use
D001323:Autoantibodies; D019774:Blood Coagulation Factor Inhibitors; D014841:von Willebrand Factor; D005169:Factor VIII